MultiXThin
MultiXThin, licence 80109511: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- MultiXThin Suspension, SmoothLD, Smoothld-60%
- Licence holder
- Voyageur Pharmaceuticals Ltd.
- NPN or DIN-HM
- 80109511
- Status
- Active licence
- Licence date
- 26 April 2021
- Revision date
- Not provided
- Form
- Suspension
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide sulfurique, sel de barium (1:1) | 60.0 % (p/v) | Not calculated |
Non-medicinal ingredients
Carraghénine de sodium, Sorbate de potassium, Sorbitol, Eau purifiée, Acide citrique monohydraté, Siméthicone, Gomme de xanthane, Citrate de sodium, Gomme arabique, 4-hydroxy-3-méthoxybenzaldéhyde, Sacharinate de sodium, Benzoate de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | maximum: 13.0 Année(s) | 1.0 Portions | 1.0 Tous les jours |
| Adultes et adolescents | minimum: 9.0 Année(s) ; maximum: 13.0 Année(s) | 1.0 Portions | 1.0 Tous les jours |
| Enfants | minimum: 4.0 Année(s) ; maximum: 8.0 Année(s) | 1.0 Portions | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
For radiographic examination of the gastrointestinal tract. For use as a single contrast radiological medium examination of the esophagus, stomach, and small bowel by conventional X-Ray.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80109511
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.